$343,80
▲ +$5,42
(+1,60%)
Vol. 174K
Cap. mercato
$129.3B
P/E
39,8
ROE
15,0%
Margine
12,9%
Beta
0,89
Rendimento div.
1,04%
52W
$319–$405
Consenso Wall Street
36 analisti · Apr 202612
Acquisto forte
15
Compra
9
Mantieni
0
Vendi
0
Vendita forte
75,0%
Rating Compra
Grafico dei Prezzi
Titoli simili
ABT
Abbott Laboratories
P/E 26,3
$165.2B
ISRG
Intuitive Surgical Inc
P/E 73,1
$200.8B
BSX
Boston Scientific Corp
P/E 32,7
$94.9B
IDXX
IDEXX Laboratories Inc
P/E 52,6
$54.0B
EW
Edwards Lifesciences Corp
P/E 42,3
$45.4B
BDX
Becton Dickinson and Co
P/E 25,1
$44.1B
GEHC
GE Healthcare Technologies Inc
P/E 16,9
$37.4B
RMD
Resmed Inc
P/E 22,0
$32.7B
DXCM
Dexcom Inc
P/E 35,9
$25.9B
ZBH
Zimmer Biomet Holdings, Inc
P/E 26,7
$18.8B
Utili
Tasso di battuta: 100,0%| Trimestre | EPS Stimato | EPS Effettivo | Sorpresa |
|---|---|---|---|
| Dic 2025 | $4,44 | $4,47 | +$0,03 |
| Set 2025 | $3,16 | $3,19 | +$0,03 |
| Giu 2025 | $3,10 | $3,13 | +$0,03 |
| Mar 2025 | $2,73 | $2,84 | +$0,11 |
Ricavi e utili trimestrali
| Trimestre | 2024-1… | 2025-0… | 2025-0… | 2025-0… | 2025-1… |
|---|---|---|---|---|---|
| Ricavi | $6.4B | $5.9B | $6.0B | $6.1B | $7.2B |
| Utile netto | $546.0M | $654.0M | $884.0M | $859.0M | $849.0M |
Trend fondamentali
| Metrica | 2026-04-12 | 2026-04-17 |
|---|---|---|
| ROE (TTM) | 15.0% | 15.0% |
| P/E (TTM) | 39.98 | 39.83 |
| Net Margin | 12.9% | 12.9% |
| Gross Margin | 64.6% | 64.6% |
| D/E Ratio | — | — |
| Current Ratio | 1.89 | 1.89 |
Rapporti chiave
ROA (TTM)
6,9%
P/S (TTM)
5,15
P/B
6,0
EPS (TTM)
$8,40
CF/Share
$9,43
Crescita ricavi 3A
+10,8%
52W High
$404,87
52W Low
$319,32
$319,32
Intervallo 52 settimane
$404,87
Salute finanziaria
Flusso di cassa libero
$1.9B
Debito netto
$11.8B
Liquidità
$4.0B
Debito totale
$15.9B
Aggiornato al Dic 31, 2025
Як SYK виглядає на тлі конкурентів у Health Care?
Група порівняння: Peers · Health Care (Peers) · 10 компаній
Оцінка SYK vs аналоги Health Care
P/E
40,0
▲
18%
sopra
peer
(33,8)
vs Peer
vs Settore
Sopravvalutato
P/S
5,2
▼
5%
sotto
peer
(5,5)
vs Peer
vs Settore
Valore equo
P/B
6,0
▲
1%
sopra
peer
(5,9)
vs Peer
vs Settore
Valore equo
Дивідендна дохідність
1,0%
▼
1%
sotto
peer
(1,1%)
vs Peer
vs Settore
Rendimento basso
Прибутковість SYK vs аналоги Health Care
ROE
15,0%
▼
3%
sotto
peer
(15,6%)
vs Peer
vs Settore
In linea
Net margin
12,9%
▼
16%
sotto
peer
(15,3%)
vs Peer
vs Settore
Debole
Валова маржа
64,6%
▲
5%
sopra
peer
(61,3%)
vs Peer
vs Settore
In linea
ROA
6,9%
▼
12%
sotto
peer
(7,9%)
vs Peer
vs Settore
Debole
Фінансове здоровʼя SYK vs аналоги Health Care
D/E ratio
—
▼
0%
sotto
peer
(77,3)
vs Peer
vs Settore
In linea
Поточна ліквідність
1,9
▲
18%
sopra
peer
(1,6)
vs Peer
vs Settore
Sotto media
Beta
0,9
▼
3%
sotto
peer
(0,9)
vs Peer
vs Settore
Meno volatile
Радар фундаменталів SYK
SYK
Mediana peer
Industria
SYK прибутковість vs борг
Розмір бульбашки = капіталізація · X = чиста маржа · Y = D/E ratio
SYK vs аналоги: ключові метрики
Dividendi
$3,44
/ anno
Mar 31, 2026
$0,8800
Dic 31, 2025
$0,8800
Set 30, 2025
$0,8400
Giu 30, 2025
$0,8400
Mar 31, 2025
$0,8400
Dic 31, 2024
$0,8400
Set 30, 2024
$0,8000
Giu 28, 2024
$0,8000
Ultime notizie
Nessuna notizia correlata ancora